| 0078-0860 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0860 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0860 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0860 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0860 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0860 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0860 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0860 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0860 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0860 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0860 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0860 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0860 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0860 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0867 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0867 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0867 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0867 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0867 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0867 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0867 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0867 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0867 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0867 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0867 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0867 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0867 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0867 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0874 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0874 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0874 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0874 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0874 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0874 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0874 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0874 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0874 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0874 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0874 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0874 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0874 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0874 | KISQALI | ribociclib | Novartis Pharmaceuticals Corporation | NDA | Current |